Article | May 8, 2019

Is Your Clinical Trial In Need Of A Rescue?

Source: Biorasi

By Wayne Bowden

Biorasi Is Your Clinical Trial In Need Of A Rescue?

A 2018 study out of MIT Sloan School of Management showed only 13.8% of drug development programs lead to FDA approval. That’s an improvement from previous estimates, which hovered at around 10%, but still an alarmingly high failure rate. In today’s competitive market, reducing failure rate is one sure way to maintain R&D returns.

While issues around safety and efficacy cause most clinical trial failures, lack of funding, poor study design, challenges around inclusion and exclusion criteria, low patient recruitment and retention, and simple mismanagement can all send a trial down the tubes.

Don’t assume your clinical trial will survive endless change orders, extended deadlines, cost overruns, and missed objectives. Recognizing early warning signs that your trial is in trouble, and taking quick decisive action, can often get studies back on track. Improving operations can solve most failure risk factors, thus increasing the odds of success.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader